Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis

被引：0

作者：

Mario Scartozzi

Gianluca Svegliati Baroni

Luca Faloppi

Marzia Di Pietro Paolo

Chiara Pierantoni

Roberto Candelari

Rossana Berardi

Stefania Antognoli

Cinzia Mincarelli

Andrea Risaliti

Cristina Marmorale

Ettore Antico

Antonio Benedetti

Stefano Cascinu

机构：

[1] AO Ospedali Riuniti-Università Politecnica delle Marche,Clinica di Oncologia Medica

[2] AO Ospedali Riuniti-Università Politecnica delle Marche,Clinica di Gastroenterologia

[3] Università Politecnica delle Marche,Scuola di Specializzazione in Oncologia

[4] Ospedale Profili,Oncologia Medica

[5] AO Ospedali Riuniti,Radiologia Interventistica

[6] AO Ospedali Riuniti-Università Politecnica delle Marche,Chirurgia Epatobiliare e dei Trapianti

[7] AO Ospedali Riuniti-Università Politecnica delle Marche,Clinica Chirurgica

来源：

Journal of Experimental & Clinical Cancer Research | / 29卷

关键词：

Overall Survival; Sorafenib; Tace; Staging System; Transarterial Chemoembolization;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

More data about TACE and pTACE seem necessary to better define the global treatment strategy for HCC. Aim of our analysis was to evaluate the role of TACE, either with lipiodol (traditional) or drug-eluting microspheres in terms of response rate (RR), time to progression (TTP), overall survival (OS) and toxicity in HCC.

引用

共 40 条

[1]

Parkin DM(2005)Global cancer statistics, 2002 Ca Cancer J Clin 55 74-108

[2]

Bray F(2002)Epidemiology, risk factors and natural history of hepatocellular carcinoma Ann N Y Acad Sci 963 13-20

[3]

Ferlay J(2005)Update treatment approach to hepatocellular carcinoma J Gastroenterol 40 225-235

[4]

Montalto G(2003)Small hepatocellular carcinoma in cirrhosis: randomized controlled trial of radiofrequency thermal ablation versus percutaneous ethanol injection Radiology 228 235-240

[5]

Cervello M(2004)Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma of 4 cm or less Gastroenterology 127 1714-1723

[6]

Giannitrapani L(1998)Chemotherapy in hepatocellular carcinoma Hepatogastroenterology 45 1259-1263

[7]

Llovet JM(2006)Phase II study of sorafenib in patients with advanced hepatocellular carcinoma J Clin Oncol 24 4293-4300

[8]

Lencioni R(2008)Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma J Nat Cancer Inst 100 698-711

[9]

Allagaier HP(1995)A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma N Engl J Med 332 1256-61

[10]

Cioni D(1998)Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized controlled trial in a single institution Hepatology 27 1578-83

← 1 2 3 4 →